Indian firm likely to market coronavirus vaccine by October, if human trials are successful
It is reported that Pune based firm, Serum Institute of India, which is claimed to be partnered with Oxford University as one of the seven global institutions, may start manufacturing of coronavirus vaccine by two weeks time. It is planned to make available in the market by October if the human trials are successful.
As reported by media Adar Poonawalla chief executive officer of the firm has said that “ the company will be manufacturing the vaccine in anticipation of clinical trials succeeding by September-October in the UK. Following that,SII has undertaken the decision to initiate the manufacture at their own risk.”
“The decision has been solely taken to have a jump-start on manufacturing, to have enough doses available, if the clinical trials work,” he added
“Our team has been working closely with Dr Hill (professor Adrian Hill) from Oxford University, and we are expecting to initiate production of the vaccine in two-three weeks and produce five million doses per month for the first 6 months, following which, we hope to scale up production to 10 million doses per month,” he also said.
The human safety trials of the sixth coronavirus vaccine started in Oxford last Thursday. Scientists are planning one million doses of vaccines to make available in the market, if the human trials are successful.